©The Author(s) 2021.
World J Cardiol. Sep 26, 2021; 13(9): 493-502
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Table 3 Procedural features and outcomes
| Feature | n (%) |
| Anticoagulation | |
| Heparin only | 12 (34) |
| Bivalirudin | 8 (23) |
| Heparin + GP IIb IIIa inhibitor | 15 (43) |
| Thrombectomy | 20 (57) |
| Distal protection device | 9 (26) |
| Number of stents (mean ± SD) | 2.1 ± 1.3 |
| Total stent length (mean ± SD) | 52 ± 35 mm |
| Stent type | |
| Drug-eluting | 19 (55) |
| Bare metal | 11 (31) |
| None | 5 (14) |
| Procedural outcome | |
| Success | 29 (83) |
| Failed | 6 (17) |
| Procedural complications | |
| Distal embolization | 1 (3) |
| No reflow | 5 (15) |
| In-hospital MACE | |
| Death | 2 (5.7) |
| Myocardial infarction | 1 (2.9) |
| Stroke | 0 |
| Repeat PCI or CABG | 0 |
| Any MACE | 3 (8.6) |
- Citation: Nardone EW, Madsen BM, McCarey MM, Fischman DL, Ruggiero NJ, Walinsky P, Vishnevsky A, Savage MP. Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility? World J Cardiol 2021; 13(9): 493-502
- URL: https://www.wjgnet.com/1949-8462/full/v13/i9/493.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i9.493